node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ACSF2 | BCAS3 | ENSP00000300441 | ENSP00000375067 | acyl-CoA synthetase family member 2; Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipodyte differentiation | breast carcinoma amplified sequence 3 | 0.554 |
ACSF2 | BCAS4 | ENSP00000300441 | ENSP00000351642 | acyl-CoA synthetase family member 2; Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipodyte differentiation | breast carcinoma amplified sequence 4 | 0.504 |
ACSF2 | USP32 | ENSP00000300441 | ENSP00000300896 | acyl-CoA synthetase family member 2; Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipodyte differentiation | ubiquitin specific peptidase 32 | 0.534 |
BCAS2 | BCAS3 | ENSP00000358554 | ENSP00000375067 | breast carcinoma amplified sequence 2; Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex | breast carcinoma amplified sequence 3 | 0.466 |
BCAS2 | BCAS4 | ENSP00000358554 | ENSP00000351642 | breast carcinoma amplified sequence 2; Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex | breast carcinoma amplified sequence 4 | 0.477 |
BCAS3 | ACSF2 | ENSP00000375067 | ENSP00000300441 | breast carcinoma amplified sequence 3 | acyl-CoA synthetase family member 2; Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipodyte differentiation | 0.554 |
BCAS3 | BCAS2 | ENSP00000375067 | ENSP00000358554 | breast carcinoma amplified sequence 3 | breast carcinoma amplified sequence 2; Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex | 0.466 |
BCAS3 | BCAS4 | ENSP00000375067 | ENSP00000351642 | breast carcinoma amplified sequence 3 | breast carcinoma amplified sequence 4 | 0.867 |
BCAS3 | PHACTR3 | ENSP00000375067 | ENSP00000360054 | breast carcinoma amplified sequence 3 | phosphatase and actin regulator 3 | 0.471 |
BCAS4 | ACSF2 | ENSP00000351642 | ENSP00000300441 | breast carcinoma amplified sequence 4 | acyl-CoA synthetase family member 2; Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipodyte differentiation | 0.504 |
BCAS4 | BCAS2 | ENSP00000351642 | ENSP00000358554 | breast carcinoma amplified sequence 4 | breast carcinoma amplified sequence 2; Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex | 0.477 |
BCAS4 | BCAS3 | ENSP00000351642 | ENSP00000375067 | breast carcinoma amplified sequence 4 | breast carcinoma amplified sequence 3 | 0.867 |
BCAS4 | DEPDC1B | ENSP00000351642 | ENSP00000265036 | breast carcinoma amplified sequence 4 | DEP domain containing 1B | 0.464 |
BCAS4 | FAM190A | ENSP00000351642 | ENSP00000329482 | breast carcinoma amplified sequence 4 | family with sequence similarity 190, member A | 0.480 |
BCAS4 | PHACTR3 | ENSP00000351642 | ENSP00000360054 | breast carcinoma amplified sequence 4 | phosphatase and actin regulator 3 | 0.601 |
BCAS4 | RSBN1 | ENSP00000351642 | ENSP00000261441 | breast carcinoma amplified sequence 4 | round spermatid basic protein 1 | 0.495 |
BCAS4 | USP32 | ENSP00000351642 | ENSP00000300896 | breast carcinoma amplified sequence 4 | ubiquitin specific peptidase 32 | 0.533 |
BCAS4 | ZFP64 | ENSP00000351642 | ENSP00000216923 | breast carcinoma amplified sequence 4 | zinc finger protein 64 homolog (mouse); May be involved in transcriptional regulation | 0.520 |
BCAS4 | ZNF217 | ENSP00000351642 | ENSP00000304308 | breast carcinoma amplified sequence 4 | zinc finger protein 217; Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at ’Ser-473’ | 0.487 |
DEPDC1B | BCAS4 | ENSP00000265036 | ENSP00000351642 | DEP domain containing 1B | breast carcinoma amplified sequence 4 | 0.464 |